Costs From ICER’s Unsupported Price Increase List Tick Back Up
Overall Tally Is $1.27bn Added Expenses For US Health Care System
Humira topped ICER’s list of drugs with unsupported price increases that added the most cost to the US health care system during 2022, its last year before biosimilars hit the US market.
